SD Biosensor Signs Supply Contract Worth 148.3 Billion KRW with Japanese Government

COVID-19 and Flu Simultaneous Diagnostic Kits, etc.

[Asia Economy Reporter Lee Gwan-joo] SD Biosensor announced on the 18th that it has signed a supply contract worth 148.3 billion KRW with the Japanese government for simultaneous COVID-19 and influenza diagnostic kits as well as COVID-19 self-test kits.

The simultaneous COVID-19 and influenza diagnostic kits supplied to the Japanese government by SD Biosensor can detect infections of COVID-19 variants including Omicron and Delta, as well as Influenza A and B, within 15 minutes.

Japan recorded 250,000 COVID-19 cases on the 10th and has since been on a gradual decline. The Japanese government is currently considering stopping the full-scale identification of all infected individuals and downgrading COVID-19 from a Class 2 to a Class 5 disease. If the infectious disease classification changes, COVID-19 will no longer require full investigations, contact tracing, or hospitalization recommendations, similar to seasonal influenza.

An SD Biosensor official stated, “The Japanese government’s consideration of managing COVID-19 and influenza under the same classification appears to have increased demand for simultaneous diagnostic kits,” and added, “As the simultaneous outbreak of COVID-19 and influenza is strongly anticipated in the second half of this year, we will do our best to quickly supply simultaneous diagnostic products.”

This content was produced with the assistance of AI translation services.